Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity.
Phase of Trial: Phase II
Latest Information Update: 30 Nov 2015
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinopathy of prematurity
- Focus Pharmacokinetics; Therapeutic Use
- 30 Nov 2015 New trial record